CURRENT FOCUS

What if skin type is the wrong question?

Geraint Thomas Bio follows questions like these through the biology underneath them. Right now, the focus is epidermal biology and the science behind skincare, with new topics added as the work develops.

evidence in context

What can a cell study really tell us?

barrier signalling

How does skin detect damage?

measurement

What does TEWL actually measure?

Ways into the science

01 / Foundations

Scratch the surface.

Start with the core biology behind the subject.

The Ingredient Worked in Cells. Does That Mean It Works on Skin?

When Does Urea Stop Being a Moisturiser?

Why Does Skin Feel Tight After Cleansing?

03 / Deep dives

Down the rabbit hole.

Take one question through the evidence and the competing explanations.

The Damaged Skin Barrier

The long-form version of the questions that started this site.

Written for scientifically curious readers and skin professionals.

Cover of The Damaged Skin Barrier: A Biochemist's Guide to Barrier Biology, Damage and Repair, by Geraint Thomas
252REFERENCES
24ORIGINAL FIGURES
11CHAPTERS
0ROUTINES

The skin, by scale.

Six depths, from the whole organ to a single molecule. Select one to zoom in.

10 cm
1 cm
1 mm
100 nm

Zoomed in · illustrative, not to scale

01 · The organ

The body's boundary.

Roughly 1.5 to 2 m² of surface

Around two square metres of tissue deciding, continuously, what gets in and what stays. Most of that decision is made in the outermost fraction of a millimetre.

02 · The epidermis

Rebuilt from the bottom up.

About 0.1 mm over most of the body

Roughly the thickness of a sheet of paper. New cells form at the base and take around six weeks to reach the surface, changing all the way up.

03 · The stratum corneum

Dead, and still working.

15 to 20 cell layers, 10 to 20 µm

The outermost layers are no longer alive in the cellular sense. They still hold water in, keep most things out and shed on a controlled schedule.

04 · The corneocyte

The brick.

30 to 40 µm across, under 1 µm thick

A flattened cell packed with keratin and sealed inside a cornified envelope. Wide and extraordinarily thin, tiled against its neighbours.

05 · The lipid matrix

The mortar.

Lamellae repeating at roughly 13 nm

Ceramides, cholesterol and free fatty acids stacked in ordered sheets between the corneocytes. Their organisation sets how quickly water escapes.

06 · The molecule

Where the barrier is decided.

A few nanometres

Filaggrin, ceramides and the enzymes that process them. Most of what happens at the surface was settled here, long before it arrived.

Scale figures are approximate adult values. Images are illustrations.

Trace the claim.

Every claim should have a paper trail.

Pick a claim and pull on it. Each underlined phrase hides a question about what was actually done.

A result is only as strong as the experiment behind it.

The claim

.

Select an underlined phrase.
Ask

Loss how?

A strong answer

Inherited loss-of-function variants, seen in large genetic studies and reproduced in animal models.

A weak one

Lower filaggrin in inflamed skin. Inflammation itself switches filaggrin down, so this can't tell cause from effect.

Ask

What exactly was measured?

A strong answer

Genotype and protein level, measured separately. The gene's long repeats make it hard to sequence.

A weak one

One antibody stain on a biopsy.

Ask

Cause, or just correlated?

A strong answer

Present from birth, effect rising with the number of faulty copies, and replicated in independent cohorts.

A weak one

Skin samples compared at a single point in time.

Ask

For whom, and how much of it?

A strong answer

An effect size, including the carriers who never develop it.

A weak one

"Causes", with no word on how many people it fails to explain.

The claim

to .

Select an underlined phrase.
Ask

Is it selective, and is it the target?

A strong answer

A dose-response curve, plus a genetic knockdown of the target that gives the same result.

A weak one

One compound at one dose. Many inhibitors hit more than their named target.

Ask

More than the sum of the parts?

A strong answer

A formal synergy analysis across a range of doses.

A weak one

The combination kills more than either alone, read as synergy. Two additive effects look identical.

Ask

Which cells?

A strong answer

Several cell lines, ideally primary cells, with healthy cells as a safety check.

A weak one

One cell line, grown in a dish for years.

Ask

Death, or a drop in a readout?

A strong answer

Caspase cleavage or annexin V staining, which show apoptosis directly.

A weak one

A viability dye, which measures metabolic activity and not death.

The claim

of protein X .

Select an underlined phrase.
Ask

Where was the line drawn?

A strong answer

A threshold set before looking at outcomes, or tested in a second cohort.

A weak one

The cut-off that gave the best result in the same data.

Ask

Expression of what, and where?

A strong answer

Protein measured in the relevant cell type, with mRNA as support.

A weak one

Bulk mRNA from a sample that mixes tumour with everything around it.

Ask

Predicts, or just tracks?

A strong answer

Holds after adjusting for stage and age, and in a separate cohort.

A weak one

A correlation in one dataset. Stage alone might explain it.

Ask

Worse by what measure?

A strong answer

A defined endpoint such as overall survival, with enough events and follow-up to trust it.

A weak one

A vague "prognosis" from few patients and a short follow-up.

Not in the sentence, still worth asking

How many, and how independent?

Biological replicates are separate experiments or people. Technical replicates are the same sample measured again. Three wells is not an n of three.

Who measured, and did they know the answer?

Blinding matters most where the readout involves judgement, like scoring a stain or grading a lesion.

Has anyone else got the same result?

One lab with one method is a lead. A different lab with a different method is evidence.

Geraint Thomas, biochemist and author
Geraint Thomas, MBiochemBiochemist and science writerCardiff, South Wales

Hello, I'm Geraint.

I’m a biochemist interested in how biological systems behave, adapt, and more so, when and why they fail.

I took an integrated master’s in biochemistry at Cardiff University and graduated with a First. My research year was at the European Cancer Stem Cell Research Institute, studying how breast cancer stem-like cells resist death-receptor signalling.

After that I spent several years outside science. Skin biology is what brought me back.

The way of thinking carried over: what was measured, in what, and what does the mechanism say? The epidermis turned out to be a good place to use it. It became The Damaged Skin Barrier and this site. I wrote the book, drew its figures and built the platform myself.

First Class MBiochemCardiff UniversityTNF-family signallingLucidum Press

Where next?

Read, check a source, or meet the person behind it. Every route leads back to the evidence.